Welcome Guest | Register / Login

Oncology Market Research Reports

Sort By
Title Published Price
US Oncology Testing Market 2023: Shares and Sales Segment Forecasts By Assay
By Venture Planning Group
This report provides an overview of the US cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment. Contains 25 pages and 7 tables ...
Jul 2019 $ 850
UK Oncology Testing Market 2023: Shares and Sales Segment Forecasts By Assay
By Venture Planning Group
This report provides an overview of the UK cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment. Contains 25 pages and 7 tables ...
Jul 2019 $ 450
Spain Oncology Testing Market 2023: Shares and Sales Segment Forecasts By Assay
By Venture Planning Group
This report provides an overview of the Spanish cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment. Contains 25 pages and 7 tables ...
Jul 2019 $ 750
Japan Oncology Testing Market 2023: Shares and Sales Segment Forecasts By Assay
By Venture Planning Group
This report provides an overview of the Japanese cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment. Contains 25 pages and 7 tables ...
Jul 2019 $ 750
Italy Oncology Testing Market 2023: Shares and Sales Segment Forecasts By Assay
By Venture Planning Group
This report provides an overview of the Italian cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment. Contains 25 pages and 7 tables ...
Jul 2019 $ 650
Germany Oncology Testing Market 2023: Shares and Sales Segment Forecasts By Assay
By Venture Planning Group
This report provides an overview of the German cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment. Contains 25 pages and 7 tables ...
Jul 2019 $ 750
France Oncology Testing Market 2023: Shares and Sales Segment Forecasts By Assay
By Venture Planning Group
This report provides an overview of the French cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment. Contains 25 pages and 7 tables...
Jul 2019 $ 750
AVEO Oncology Inc (AVEO) - Financial and Strategic SWOT Analysis Review
By GlobalData
AVEO Oncology Inc (AVEO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased v...
Jun 2019 $ 125
Clovis Oncology Inc (CLVS) - Financial and Strategic SWOT Analysis Review
By GlobalData
Clovis Oncology Inc (CLVS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased...
May 2019 $ 125
Global Oncology/Cancer Blockbuster Drugs Market Research Report 2019 - 2025
By DPI Research
The global 27 cancer blockbuster drugs market size is set to surpass US$ 120 billion by 2025. “Global Oncology/Cancer Blockbuster Drugs Market Research Report 2019 - 2025” presents an in-depth ...
Apr 2019 $ 1390
21st Century Oncology Inc - Strategic SWOT Analysis Review
By GlobalData
21st Century Oncology Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's ...
Apr 2019 $ 125
US Oncology Testing Market Shares and Sales Segment Forecasts By Assay, 2019-2023
By Venture Planning Group
This report provides an overview of the US cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.Contains 40 pages and 7 tables...
Apr 2019 $ 850
UK Oncology Testing Market Shares and Sales Segment Forecasts By Assay, 2019-2023
By Venture Planning Group
This report provides an overview of the U.K. cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.Contains 16 pages and 4 tables...
Apr 2019 $ 450
Spain Oncology Testing Market Shares and Sales Segment Forecasts By Assay, 2019-2023
By Venture Planning Group
This report provides an overview of the Spanish cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.Contains 16 pages and 7 tables...
Apr 2019 $ 750
Japan Oncology Testing Market Shares and Sales Segment Forecasts By Assay, 2019-2023
By Venture Planning Group
This report provides an overview of the Japanese cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.Contains 23 pages and 6 tables...
Apr 2019 $ 750
Italy Oncology Testing Market Shares and Sales Segment Forecasts By Assay, 2019-2023
By Venture Planning Group
This report provides an overview of the Italian cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.Contains 18 pages and 5 tables...
Apr 2019 $ 650
Germany Oncology Testing Market Shares and Sales Segment Forecasts By Assay, 2019-2023
By Venture Planning Group
This report provides an overview of the German cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.Contains 25 pages and 7 tables...
Apr 2019 $ 750
France Oncology Testing Market Shares and Sales Segment Forecasts By Assay, 2019-2023
By Venture Planning Group
This report provides an overview of the French cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.Contains 25 pages and 7 tables...
Apr 2019 $ 750
Kura Oncology Inc (KURA) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Kura Oncology Inc (Kura Oncology) is a clinical-stage biopharmaceutical company that discovers and develops therapeutics for the treatment of solid tumors and blood cancers. The company's lead drug candidate Tipifarnib, an inhibi...
Mar 2019 $ 300
Champions Oncology Inc (CSBR) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Champions Oncology Inc (Champions), formerly Champions Biotechnology Inc, is a developer of advanced technology solutions and services to personalize the development and use of oncology drugs. The company's technology platform is...
Mar 2019 $ 300
ZIOPHARM Oncology Inc (ZIOP) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Ziopharm Oncology Inc (Ziopharm), is a provider of next-generation immune therapies. The company offers Controlled IL-12 and t-cell therapy to fight blood cancers and solid tumors. Its Controlled IL-12 platform provides therapy ...
Mar 2019 $ 300
The US Oncology Network - Strategic SWOT Analysis Review
By GlobalData
The US Oncology Network - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's ke...
Feb 2019 $ 125
Champions Oncology Inc (CSBR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
By GlobalData
Summary Champions Oncology Inc (Champions), formerly Champions Biotechnology Inc, is a developer of advanced technology solutions and services to personalize the development and use of oncology drugs. The company's technology platform is...
Nov 2018 $ 250
Gritstone Oncology Inc (GRTS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
By GlobalData
Summary Gritstone Oncology Inc (Gritstone) develops and commercialize tumor-specific cancer immunotherapies. The company's pipeline product portfolio comprises GRANITE-001, for solid tumors, including metastatic non-small cell lung cance...
Nov 2018 $ 250
Strata Oncology Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
By GlobalData
Summary Strata Oncology Inc (Strata Oncology) is a precision oncology company. The company offers tumor sequencing to advanced cancer patients and a portfolio of biomarker-matched precision medicine trials. It identifies patients to desi...
Nov 2018 $ 250
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy